September 2, 2015
Eisai announced on August 31 that its US subsidiary Eisai Inc. and US-based Purdue Pharma have entered into a worldwide collaboration agreement for the development and promotion of Eisai’s investigational insomnia treatment lemborexant (development code: E2006). Lemborexant, discovered by Eisai,...read more